HIF1A and metastatic neoplasm: In both situations, the HIF1-α gene moves to the cell nucleus, promoting VEGFA and PDGFa transcription [10, 23], As a result many drugs targeting angiogenesis have been developed and are currently being used to treat metastatic disease [24–26].